Investing Ideas
/
U.S. Pharmaceuticals & Biotech Low-Risk Leaders

U.S. Pharmaceuticals & Biotech Low-Risk Leaders

Results

2 new

Every great portfolio needs a good foundation. Our selection of stocks can help you lower your risk without sacrificing your returns. Invest in the market's most resilient companies with strong balance sheets and the lowest risk scores in our model.

4 companies

Kiniksa Pharmaceuticals International

Market Cap: US$5.7b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

New

KNSA

US$75.99

-4.3%

129.8%

Neurocrine Biosciences

Market Cap: US$16.9b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

NBIX

US$166.06

-8.1%

29.3%

United Therapeutics

Market Cap: US$22.0b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

UTHR

US$518.68

-1.1%

71.5%

Vertex Pharmaceuticals

Market Cap: US$121.3b

Operates as a biotechnology company in the United States, Europe, and internationally.

New

VRTX

US$478.71

-1.0%

24.1%